Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCHOpen Access

Serum Levels of MicroRNA-210 as a Pathogenic Factor in Patients with Diabetes and Diabetic Nephropathy: A Cross-sectional Study

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDivya SinghISIvvala Anand ShakerAAAshishkumar Agravatt

Discussion

Loading...

Member takes

Overview

Cross-sectional study assesses microRNA-210 levels in diabetes patients, revealing implications for nephropathy.

Key Points

  • Significant differences in serum markers exist among the control, diabetic, and nephropathy groups.
  • Elevated C-Reactive Protein levels were found in both diabetic groups at 10.591 mg/L and 18.710 mg/L.
  • Reduced adiponectin levels were observed in nephropathy patients at 21.340 µg/mL compared to controls.
  • Findings suggest that microRNA-210 could serve as a biomarker for early detection of complications.

Cite This Study

Singh et al. (2025) studied this question.

synapsesocial.com/papers/68c23caeb210217d6478a756https://doi.org/10.7860/jcdr/2025/80307.21511
View Full Paper
Ask AI
Bookmark
Share